Thailand Partners with Innovax to Expand Vaccine Production
The Thai Ministry of Public Health is collaborating with Innovax to develop shingles and RSV vaccines, aiming to establish Thailand as a regional manufacturing hub.
The Thai Ministry of Public Health has announced a strategic partnership with Innovax to build upon the success of the HPV9 vaccine program. According to a report by Matichon Online, this collaboration aims to expand local production capabilities to include vaccines for shingles and Respiratory Syncytial Virus (RSV). The initiative is part of a broader effort to position Thailand as a primary manufacturing and export hub for vaccines within the ASEAN region. For residents and long-term visitors, this development signals a potential increase in the local availability of advanced preventative healthcare options in the coming years. By strengthening domestic production, the government hopes to improve public health security and reduce reliance on imported medical supplies. While the partnership marks a significant step toward regional leadership in biotechnology, specific timelines for the mass production and distribution of these new vaccines have not yet been finalized. Further details regarding the regulatory approval process and the expected rollout schedule for these specific vaccines remain to be confirmed by health authorities.